Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria

BMC Medical Ethics

Charles N Rotimi¹  Jie Zhou¹  Teri Strenski³  Temidayo O Ogundiran⁵  Adebowale A Adeyemo¹  Clement A Adebamowo⁴  Patricia A Marshall² 

[1] Center for Research on Genomics and Global Health, National Institutes of Health, Building 12A, Room 4047, 12 South Dr, MSC 5635, Bethesda, MD, 20892-5635, USA;Department of Bioethics, School of Medicine, Room TA 227Case Western Reserve University10900 Euclid Avenue Cleveland, Ohio 44106-4976 Cleveland, USA;Feinberg School of Medicine, Northwestern University, 750 N Lake Shore Dr, Chicago, IL 60611, USA;Department of Epidemiology and Public Health, Institute of Human Virology and Greenebaum Cancer Center of the University of Maryland School of Medicine, Baltimore Howard Hall Suite 200, 660 W. Redwood Street, Baltimore, MD 21201, USA;Division of Oncology, Department of Surgery, University College Hospital, Ibadan, Nigeria

关键词: Nigeria;    Breast cancer;    Genetic epidemiological research;    Informed consent;   

Others  :  799530
DOI  :  10.1186/1472-6939-15-38

 received in 2013-08-01, accepted in 2014-05-01,  发布年份 2014

【 摘 要 】

Background

Studies on informed consent to medical research conducted in low or middle-income settings have increased, including empirical investigations of consent to genetic research. We investigated voluntary participation and comprehension of informed consent among women involved in a genetic epidemiological study on breast cancer in an urban setting of Nigeria comparing women in the case and control groups.

Methods

Surveys were administered in face-to-face interviews with 215 participants following their enrollment in the genetic study (106 patients, 109 controls). Audio-taped in-depth interviews were conducted with a sub-sample of 17 (8%) women who completed the survey.

Results

The majority of all participants reported being told that participation in the genetic study was voluntary (97%), that they did not feel pressured to participate in the study (99%), and that they could withdraw from the study (81%). The majority of the breast cancer patients (83%) compared to 58% of women in the control group reported that the study purpose was to learn about the genetic inheritance of breast cancer (OR 3.44; 95% CI =1.66, 7.14, p value = 0.001). Most participants reported being told about study procedures (95%) and study benefits (98%). Sixty-eight percent of the patients, compared to 47% of the control group reported being told about study risks (p-value <0.001). Of the 165 married women, 19% reported asking permission from their husbands to enroll in the breast cancer study; no one sought permission from local elders. In-depth interviews highlight the use of persuasion and negotiation between a wife and her husband regarding study participation.

Conclusions

The global expansion of genetic and genomic research highlights our need to understand informed consent practices for studies in ethnically diverse cultural environments such as Africa. Quantitative and qualitative empirical investigations of the informed consent process for genetic and genomic research will further our knowledge of complex issues associated with communication of information, comprehension, decisional authority and voluntary participation. In the future, the development and testing of innovative strategies to promote voluntary participation and comprehension of the goals of genomic research will contribute to our understanding of strategies that enhance the consent process.

【 授权许可】

   
2014 Marshall et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Malaria Genomic Epidemiology Network: A global network for investigating the genomic epidemiology of malaria. Nature 2008, 11(456):732-737.
• [2]Chokshi DA, Kwiatkowski DP: Ethical challenges of genomic epidemiology in developing countries. Genomics Soc Policy 2005, 1:1-15. BioMed Central Full Text
• [3]Molyneux CS, Wassenaar DR, Peshu N, Marsh K: ‘Even if they ask you to stand by a tree all day, you will have to do it (laughter…!:) Community voices on the notion and practice of informed consent for biomedical research in developing countries. Soc Sci Med 2005, 61:443-454.
• [4]Chaisson LH, Kass NE, Chengeta B, Mathebula U, Samandari T: Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana. PLoS One 2011, 6(10):e22696.
• [5]Sabik L, Pace CA, Forster-Gertner HP, Wendler D, Bebchuk JD, Tavel JA, McNay LA, Killen J, Emanuel EJ, Grady C: Informed consent: practices and views of investigators in a multinational clinical trial. IRB: Ethics & Hum Res 2005, 27(5):13-18.
• [6]Pace C, Emanuel E, Chuenyam T, Duncombe C, Bebhuk JD, Wendler D, Tavel JA, McNay LA, Phanuphak P, Forster HP, Grady C: The quality of informed consent for a clinical research study in Thailand. IRB: Ethics and Hum Res 2005, 27(Suppl 1):9-17.
• [7]Pace C, Talisuma A, Wendler D, Faustin M, Wabwire-Mangen F, Bakyaita N, Okira E, Garrett-Mayer ES, Emanuel E, Grady C: Quality of parental consent in a Ugandan malaria study. Am J Public Health 2005, 95(Suppl 7):1184-1189.
• [8]Hyder AA, Wali SA: Informed consent and collaborative research: perspectives from the developing world. Dev World Bioeth 2006, 1:33-40.
• [9]Okello G, Jones C, Bonareri M, Ndegwa SN, Mcharo C, Kengo J, Kinyua K, Dubeck MM, Halliday K, Jukes MCH, Molyneux S, Brooker SJ: Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: experiences from Kenya. BioMed Centeral Trials 2013, 14:142.
• [10]Molyneux CS, Peshu N, Marsh K: Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. Soc Sci Med 2004, 59(12):2547.
• [11]Molyneux CS, Peshu N, Marsh K: Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med 2005, 61(7):1463-1473.
• [12]Gikonyo C, Bejon P, Marsh V, Molyneux S: Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast. Soc Sci Med 2008, 67(5):708-720.
• [13]Molyneux S, Gikonyo C, Marsh V, Bejon P: Incorporating a quiz into informed consent processes: qualitative study of participants’ reactions. Malar J 2007, 6:145. BioMed Central Full Text
• [14]Adams V, Miller S, Craig S, Samen A, Nyima S, Droyoung L, Varner M: The challenge of cross-cultural clinical trials research: case report from the Tibetan Autonomous Region, People’s Republic of China. Med Anthropol Q 2005, 19(3):267-289.
• [15]Boga M, Davies A, Kamuya D, Kinyanjui SM, Kivaya E, Kombe F, Lang T, Marsh V, Mbete B, Mlamba A, Molyneux S, Mulupi S, Mwalukore S: Strengthening the informed consent process in international health research through community engagement: The KEMRI-Wellcome Trust Research Programme Experience. PLoS Med 2011, 8(9):e1001089.
• [16]Osamor PE, Kass N: Decision-making and motivation to participate in biomedical research in southwest Nigeria. Dev World Bioeth 2012, 12(2):87-95.
• [17]Angwenyi V, Kamuya D, Mwachiro D, Marsh V, Njuguna P, Molyneux S: Working with Community Health Workers as ‘volunteers’ in a vaccine trial: practical and ethical experiences and implications. Dev World Bioeth 2013, 13(1):38-47.
• [18]Appiah-Poku J, Newton S, Kass N: Participants’ perceptions of research benefits in an African genetic epidemiology study. Dev World Bioeth 2011, 11(3):128-135.
• [19]Tekola F, Bull S, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G: Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: a qualitative study. BMC Med Ethics 2009, 10:13. BioMed Central Full Text
• [20]Tekola R, Bull SJ, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G: Tailoring consent to context: designing an appropriate consent process of a biomedical study in a low income setting. PLoS Negl Trop Dis 2009, 21:e482.
• [21]Bull S, Farsides B, Tekola AF: Tailoring information provision and consent process to research contexts: the value of rapid assessments. J Empir Res Hum Res Ethics 2012, 7:37-52.
• [22]Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Vekich M, Strenski T, Zhou J, Prewitt TE, Cooper RS, Rotimi CN: Voluntary participation and informed consent to international genetic research. Am J Public Health 2006, 96(11):1989-1995.
• [23]Richards MPM, Ponder M, Pharoah P, Everest S, Mackay J: Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. J Med Ethics 2003, 29(2):93-96.
• [24]Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS: Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med Ethic 2010, 15(11):13.
• [25]Tindana P, Bull S, Amenga-Etego L, De Vries J, Aborigo R, Koram K, Kwiatkowski D, Parker M: Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience. BMC Med Ethic 2012, 2:13-15.
• [26]De Vries J, Bull SJ, Doumbo O, Ibrahim M, Mercereau-Puijalon O, Kwiatkowski D, Parker M: Ethical issues in human genomics research in developing countries. BMC Med Ethics 2011, 18:12-15.
• [27]Rotimi CN, Marshall PA: Tailoring the process of informed consent in genetic and genomic research. Genome Med 2010, 24:20.
• [28]Emanuel E, Wendler D, Killen J, Grady C: What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis 2004, 189:932-937.
• [29]World Medical Association: Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Amended by the WMA General Assembly; 2013.
• [30]Nuffield Council on Bioethic: The Ethics of Research Related to Healthcare in Developing Countries. London: Nuffield Council on Bioethics; 2002.
• [31]Nuffield Council on Bioethics: he Ethics of Research Related to Healthcare in Developing Countries; Follow-Up Discussion. London: Nuffield Council Bioethics; 2005.
• [32]Council for International Organizations of Medical Sciences (CIOMS): International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: Council for International Organizations of Medical Sciences; 2002.
• [33]Council for International Organizations of Medical Sciences (CIOMS): International Guidelines for Ethical Review of Epidemiological Studies. Geneva: Council for International Organizations of Medical Sciences; 1991, draft rev; 2006.
• [34]Fadare JO, Porteri C: Informed consent in human subject research: a comparison of current international and Nigerian guidelines. J Empir Res Hum Res Ethics 2010, 5(1):67-73.
• [35]Marshall P: Ethical Issues in Research Design and Informed Consent to Biomedical and Social Research in Resource Poor Settings. Geneva: World Health Organization, Special Topics in Social, Economic, and Behavioral Research Series of Programme for Research and Training in Tropical Diseases (TDR); 2007.
• [36]Bhutta Z: Beyond informed consent. Bull World Org 2004, 82(10):771-777.
• [37]Kass N, Maman S, Atkinson J: Motivations, understanding and voluntariness in international randomized trials. IRB: Ethics and Hum Res 2005, 27(6):1-8.
• [38]DeCosta A, D’Souza N, Krishnan S, Chhabra MS, Shihaam I, Goswami K: Community based trials and informed consent in rural north India. J of Med Ethics 2004, 30:318-323.
• [39]Jegede AS: Understanding informed consent for participation in international health research. Dev World Bioeth 2009, 9(2):81-87.
• [40]Bull S, Lindegger GC: Ensuring consent to research is voluntary: how far do we need to go? Am J Bioeth 2011, 11(8):27-29.
• [41]Rivera R, Borasky D, Rivera R, Borasky D, Rice R, Carayon F, Wong E: An international researchers’ perspective. Am J Public Health 2007, 97(1):25-29.
• [42]Woodsong C, Karim QA: A model designed to enhance informed consent: experiences from the HIV Prevention Trials Network. Am J Public Health 2005, 95:412-419.
• [43]Kass NE, Chaisson L, Taylor HA, Lohse J: Length and complexity of US and international HIV consent forms from federal HIV network trials. J Gen Intern Med 2011, 26(11):1324-1328.
• [44]MacQueen KM, Shapiro K, Karim QA, Sugarman J: Ethical challenges in international HIV prevention research. Account Res 2004, 11:48-61.
• [45]Sankar P: Communication and miscommunication in informed consent to research. Med Anthro Quarterly 2004, 18(4):429-446.
• [46]Dawson L, Kass NE: Views of US researchers about informed consent in international collaborative research. Soc Sci Med 2005, 61:1211-1222.
• [47]Marshall P: Informed consent in international health research. J Empir Res Hum Res Ethics 2006, 1:25-41.
• [48]Amon JJ, Baral SD, Beyrer C, Kass N: Human rights research and ethics review: protecting individuals or protecting the state? PLoS Med 2012, 9(10):e1001325.
• [49]Marshall P: Human rights, cultural pluralism, and international health research. Theor Med Bioeth 2005, 6:529-557.
• [50]Marshall PA: The individual and the community in international genetic research. J Clinical Ethics 2004, 15(1):76-86.
• [51]Ezeome ER, Marshall PA: Informed consent practices in Nigeria. Dev World Bioeth 2009, 9(3):138-148.
• [52]Rotimi C, Leppert M, Matsuda I, Zeng C, Zhang H, Adebamowo C, Ajayi I, Aniagwu T, Dixon M, Fukushima Y, Macer D, Marshall P, Nkwodimmah C, Peiffer A, Royal C, Suda E, Zhao H, Wang VO, McEwen J: International HapMap Consortium: Community engagement and informed consent in the International HapMap project. Community Genet 2007, 10(3):186-198.
• [53]Tangwa G: Between universalism and relativism: a conceptual exploration of problems in formulating and applying international biomedical ethical guidelines. J Med Ethics 2004, 30(1):63-67.
• [54]Marshall PA: The relevance of culture for informed consent in U.S.-funded international health research. In Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries, Vol II. Bethesda, MD: National Bioethics Advisory Commission; C-1-C38; 2001.
• [55]Denizen NK, Lincoln YS: The SAGE Handbook of Qualitatiive Research. 4th edition. Thousand Oaks, Californnia: Sage Publications; 2011.
• [56]Green J: Thorogood: Qualitative Methods for Health Research. Thousand Oaks, California: Sage Publications; 2013.
• [57]Strauss A, Corbin JM: Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, California: Sage Publications; 1998.
• [58]Friese S: Qualitative Data Analysis with ATLAS.ti. Thousand Oaks, CA: Sage Publications; 2012.
• [59]Denizen NK, Lincoln YS: Collecting and Interpreting Qualitative Materials. 4th edition. Thousand Oaks, CA: Sage Publications; 2012.
• [60]Boeije H: Analysis in Qualitative Research. London: Sage Publications; 2010.
• [61]Ponder M, Statham H, Hallowell N, Moon JA, Richards M, Raymond FL: Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. J Med Ethics 2008, 34:690-694.
• [62]Hallowell N, Parry S, Cooke S, Crawford G, Lucassen A, Parker M: Lay and Professional Understandings of Research and Clinical Activities in Cancer Genetics and Their Implications for Informed Consent. AJOB Primary Res 2010, 1(2):25-34.
• [63]Jenkins N, Lawton J, Douglas M, Walker S, Finnie R, Porteous M, Hallowell N: How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? Patient Educ Couns 2013, 90:372-377.
• [64]International HapMap Consortium: Integrating science and ethics in the International HapMap Project. Nat Rev Genet 2004, 5:467-475.
• [65]H3Africa, Human Heredity and Health in Africa. http://www.h3africa.org/ webcite